AbstractPurposeDynamic contrast-enhanced CT (DCE-CT) quantifies vasculature properties of tumors, whereas static FDG-PET/CT defines metabolic activity. Both imaging modalities are capable of showing intra-tumor heterogeneity. We investigated differences in vasculature properties within primary non-small cell lung cancer (NSCLC) tumors measured by DCE-CT and metabolic activity from FDG-PET/CT.MethodsThirty three NSCLC patients were analyzed prior to treatment. FDG-PET/CT and DCE-CT were co-registered. The tumor was delineated and metabolic activity was segmented on the FDG-PET/CT in two regions: low (<50% maximum SUV) and high (⩾50% maximum SUV) metabolic uptake. Blood flow, blood volume and permeability were calculated using a maximum slope...
International audienceObjectives: Metabolically active tumor volume (MATV) and tumor activity distri...
Thirty patients with proven colorectal cancer prospectively underwent integrated 18F-FDG PET/DCE-CT ...
Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer ranked as the 5th most common ...
Purpose: Dynamic contrast-enhanced CT (DCE-CT) quantifies vasculature properties of tumors, whereas ...
AbstractPurposeDynamic contrast-enhanced CT (DCE-CT) quantifies vasculature properties of tumors, wh...
Purpose Multiple imaging techniques are nowadays available for clinical in-vivo visualization of tum...
We applied modern molecular and functional imaging to the pretreatment assessment of lung cancer usi...
To prospectively examine the relation between tumor vascularity and glucose metabolism in adenocarci...
To prospectively examine the relation between tumor vascularity and glucose metabolism in adenocarci...
OBJECTIVES: To compare tumour enhancement patterns measured using dynamic contrast-enhanced (DCE)-CT...
Application of textural features analysis to 18F-fluorodeoxyglucose (18F-FDG) positron emission tomo...
<div><p>Objectives</p><p>Diffusion-weighted magnetic resonance imaging (DW-MRI) and imaging of gluco...
F-FDG PET/DCE-CT to assess the metabolic-flow phenotype. Both CT blood flow parametric maps and PET ...
Background/Objectives: To prospectively examine the relation between tumor vascularity and glucose m...
(18)F-FDG PET is well established in the field of oncology for diagnosis and staging purposes and is...
International audienceObjectives: Metabolically active tumor volume (MATV) and tumor activity distri...
Thirty patients with proven colorectal cancer prospectively underwent integrated 18F-FDG PET/DCE-CT ...
Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer ranked as the 5th most common ...
Purpose: Dynamic contrast-enhanced CT (DCE-CT) quantifies vasculature properties of tumors, whereas ...
AbstractPurposeDynamic contrast-enhanced CT (DCE-CT) quantifies vasculature properties of tumors, wh...
Purpose Multiple imaging techniques are nowadays available for clinical in-vivo visualization of tum...
We applied modern molecular and functional imaging to the pretreatment assessment of lung cancer usi...
To prospectively examine the relation between tumor vascularity and glucose metabolism in adenocarci...
To prospectively examine the relation between tumor vascularity and glucose metabolism in adenocarci...
OBJECTIVES: To compare tumour enhancement patterns measured using dynamic contrast-enhanced (DCE)-CT...
Application of textural features analysis to 18F-fluorodeoxyglucose (18F-FDG) positron emission tomo...
<div><p>Objectives</p><p>Diffusion-weighted magnetic resonance imaging (DW-MRI) and imaging of gluco...
F-FDG PET/DCE-CT to assess the metabolic-flow phenotype. Both CT blood flow parametric maps and PET ...
Background/Objectives: To prospectively examine the relation between tumor vascularity and glucose m...
(18)F-FDG PET is well established in the field of oncology for diagnosis and staging purposes and is...
International audienceObjectives: Metabolically active tumor volume (MATV) and tumor activity distri...
Thirty patients with proven colorectal cancer prospectively underwent integrated 18F-FDG PET/DCE-CT ...
Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer ranked as the 5th most common ...